Plain-English translation of NCT07019350 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
When coronary artery disease affects a complex area where two heart arteries meet (called a bifurcation), doctors have different ways to open the blockage using a catheter. This trial is comparing two strategies: one that uses a special balloon coated with heart medication on one branch and a stent on the main artery, versus another that places stents on both branches from the start. The goal is to find out which approach helps patients have better outcomes and fewer problems down the road.
Complex bifurcation blockages are tricky to treat and carry higher risks of the artery closing again or other complications. Doctors aren't sure whether using the newer drug-coated balloon on one side while stenting the main artery works as well as, or better than, placing stents on both branches right away. This trial will help doctors choose the safest and most effective approach for patients like you.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive a catheter-based procedure to treat your heart artery blockage. You will be randomly assigned to receive one of two treatment approaches: either a drug-coated balloon on the smaller branch combined with a stent on the main artery, or stents placed on both branches. The procedure itself is similar to a standard angioplasty, and you will need follow-up visits to make sure the treatment is working well and to monitor your recovery.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
South Korea